02.04.2022 - Late-breaking presentation of analysis of SCORED clinical trial data describes significant reduction in cardiovascular death, myocardial infarction and stroke with sotagliflozin treatment as compared to placeboTHE WOODLANDS, Texas, April 02, 2022 . Seite 1